Read our previous insight-driven newsletters covering business, finance, economics and tech.
Plus: How much are Wall Street bonuses again?
Plus: Amazon has a chip on its shoulder about Nvidia.
Plus: 23andMe is calling it quits on drug development.
Plus: Rich clients stick with their advisors, but not their kids.
Plus: Nestle eyes a splashy new partnership.
Plus: Does Australia’s big push to ban kids from social media make sense?
New digital-asset funds are being issued directly on the blockchain.
Plus: Is Novo Nordisk becoming a victim of its own incredible success?